| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alpha-amylase activity | 2.19e-12 | 5 | 95 | 5 | GO:0004556 | |
| GeneOntologyMolecularFunction | amylase activity | 1.31e-11 | 6 | 95 | 5 | GO:0016160 | |
| GeneOntologyMolecularFunction | chloride ion binding | 9.18e-09 | 16 | 95 | 5 | GO:0031404 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 9.75e-06 | 103 | 95 | 6 | GO:0004553 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 6.50e-05 | 144 | 95 | 6 | GO:0016798 | |
| GeneOntologyMolecularFunction | fructose-bisphosphate aldolase activity | 6.70e-05 | 3 | 95 | 2 | GO:0004332 | |
| GeneOntologyMolecularFunction | G protein-coupled serotonin receptor binding | 2.22e-04 | 5 | 95 | 2 | GO:0031821 | |
| GeneOntologyMolecularFunction | helicase activity | 9.51e-04 | 158 | 95 | 5 | GO:0004386 | |
| GeneOntologyMolecularFunction | aldehyde-lyase activity | 1.20e-03 | 11 | 95 | 2 | GO:0016832 | |
| GeneOntologyMolecularFunction | complement component C3b binding | 1.43e-03 | 12 | 95 | 2 | GO:0001851 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | HSPG2 HMCN1 COL26A1 CILP ADAMTS9 SULF1 PRG2 MMP23B ADAMTS17 NCAM1 FREM1 | 2.87e-05 | 530 | 95 | 11 | GO:0062023 |
| GeneOntologyCellularComponent | extracellular matrix | HSPG2 HMCN1 COL26A1 LRRN1 CILP ADAMTS9 SULF1 PRG2 MMP23B ADAMTS17 NCAM1 FREM1 | 4.18e-05 | 656 | 95 | 12 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | HSPG2 HMCN1 COL26A1 LRRN1 CILP ADAMTS9 SULF1 PRG2 MMP23B ADAMTS17 NCAM1 FREM1 | 4.30e-05 | 658 | 95 | 12 | GO:0030312 |
| GeneOntologyCellularComponent | M band | 3.73e-04 | 31 | 95 | 3 | GO:0031430 | |
| Domain | Aamy_C | 5.76e-10 | 4 | 93 | 4 | SM00632 | |
| Domain | Alpha_amylase | 5.76e-10 | 4 | 93 | 4 | IPR006046 | |
| Domain | Alpha-amylase_C | 2.87e-09 | 5 | 93 | 4 | PF02806 | |
| Domain | A-amylase/branching_C | 2.87e-09 | 5 | 93 | 4 | IPR006048 | |
| Domain | Aamy | 1.99e-08 | 7 | 93 | 4 | SM00642 | |
| Domain | Glyco_hydro_13_cat_dom | 1.99e-08 | 7 | 93 | 4 | IPR006047 | |
| Domain | Alpha-amylase | 1.99e-08 | 7 | 93 | 4 | PF00128 | |
| Domain | Ig_I-set | HSPG2 CEACAM5 HMCN1 LRRN1 NRCAM CILP TRIO OBSCN NCAM1 SIGLEC11 | 3.64e-08 | 190 | 93 | 10 | IPR013098 |
| Domain | I-set | HSPG2 CEACAM5 HMCN1 LRRN1 NRCAM CILP TRIO OBSCN NCAM1 SIGLEC11 | 3.64e-08 | 190 | 93 | 10 | PF07679 |
| Domain | A-amylase_C | 1.20e-07 | 3 | 93 | 3 | IPR031319 | |
| Domain | IGc2 | HSPG2 CEACAM5 HMCN1 LRRN1 NRCAM CILP TRIO OBSCN NCAM1 SIGLEC11 | 2.66e-07 | 235 | 93 | 10 | SM00408 |
| Domain | Ig_sub2 | HSPG2 CEACAM5 HMCN1 LRRN1 NRCAM CILP TRIO OBSCN NCAM1 SIGLEC11 | 2.66e-07 | 235 | 93 | 10 | IPR003598 |
| Domain | Glyco_hydro_b | 7.54e-07 | 15 | 93 | 4 | IPR013780 | |
| Domain | Glyco_hydro_13 | 2.36e-06 | 6 | 93 | 3 | IPR015902 | |
| Domain | IG | HSPG2 CEACAM5 HMCN1 LRRN1 NRCAM CILP TRIO MMP23B OBSCN NCAM1 SIGLEC11 | 7.77e-06 | 421 | 93 | 11 | SM00409 |
| Domain | Ig_sub | HSPG2 CEACAM5 HMCN1 LRRN1 NRCAM CILP TRIO MMP23B OBSCN NCAM1 SIGLEC11 | 7.77e-06 | 421 | 93 | 11 | IPR003599 |
| Domain | - | PLXNA3 HSPG2 CEACAM5 HMCN1 LRRN1 NRCAM CILP TRIO MMP23B OBSCN NCAM1 RELB SIGLEC11 | 2.41e-05 | 663 | 93 | 13 | 2.60.40.10 |
| Domain | IG_LIKE | HSPG2 CEACAM5 HMCN1 LRRN1 NRCAM CILP TRIO MMP23B OBSCN NCAM1 SIGLEC11 | 3.24e-05 | 491 | 93 | 11 | PS50835 |
| Domain | Glyco_hydro_catalytic_dom | 3.74e-05 | 38 | 93 | 4 | IPR013781 | |
| Domain | Ig-like_dom | HSPG2 CEACAM5 HMCN1 LRRN1 NRCAM CILP TRIO MMP23B OBSCN NCAM1 SIGLEC11 | 4.03e-05 | 503 | 93 | 11 | IPR007110 |
| Domain | - | 4.18e-05 | 14 | 93 | 3 | 2.60.40.1180 | |
| Domain | ig | 4.57e-05 | 190 | 93 | 7 | PF00047 | |
| Domain | Immunoglobulin | 4.57e-05 | 190 | 93 | 7 | IPR013151 | |
| Domain | Ig-like_fold | PLXNA3 HSPG2 CEACAM5 HMCN1 LRRN1 NRCAM CILP TRIO MMP23B OBSCN NCAM1 RELB SIGLEC11 | 4.61e-05 | 706 | 93 | 13 | IPR013783 |
| Domain | FBA_I | 7.33e-05 | 3 | 93 | 2 | IPR000741 | |
| Domain | Glycolytic | 7.33e-05 | 3 | 93 | 2 | PF00274 | |
| Domain | Aldolase_I_AS | 7.33e-05 | 3 | 93 | 2 | IPR029768 | |
| Domain | ALDOLASE_CLASS_I | 7.33e-05 | 3 | 93 | 2 | PS00158 | |
| Domain | Glycoside_hydrolase_SF | 1.40e-04 | 53 | 93 | 4 | IPR017853 | |
| Domain | Neural_cell_adh | 1.46e-04 | 4 | 93 | 2 | IPR009138 | |
| Domain | TSP_1 | 2.74e-04 | 63 | 93 | 4 | PF00090 | |
| Domain | TSP1 | 3.09e-04 | 65 | 93 | 4 | SM00209 | |
| Domain | TSP1_rpt | 3.09e-04 | 65 | 93 | 4 | IPR000884 | |
| Domain | TSP1 | 3.09e-04 | 65 | 93 | 4 | PS50092 | |
| Domain | DEAD/DEAH_box_helicase_dom | 4.82e-04 | 73 | 93 | 4 | IPR011545 | |
| Domain | DEAD | 4.82e-04 | 73 | 93 | 4 | PF00270 | |
| Domain | Gprotein_alpha_I | 6.74e-04 | 8 | 93 | 2 | IPR001408 | |
| Domain | - | 6.97e-04 | 35 | 93 | 3 | 3.20.20.80 | |
| Domain | Pept_M10_metallopeptidase | 1.28e-03 | 43 | 93 | 3 | IPR001818 | |
| Domain | Helicase_C | 2.01e-03 | 107 | 93 | 4 | PF00271 | |
| Domain | HELICc | 2.01e-03 | 107 | 93 | 4 | SM00490 | |
| Domain | Helicase_C | 2.08e-03 | 108 | 93 | 4 | IPR001650 | |
| Domain | HELICASE_CTER | 2.15e-03 | 109 | 93 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 2.15e-03 | 109 | 93 | 4 | PS51192 | |
| Domain | DEXDc | 2.15e-03 | 109 | 93 | 4 | SM00487 | |
| Domain | Helicase_ATP-bd | 2.22e-03 | 110 | 93 | 4 | IPR014001 | |
| Domain | Quinoprotein_ADH-like_supfam | 2.34e-03 | 53 | 93 | 3 | IPR011047 | |
| Domain | G-alpha | 2.81e-03 | 16 | 93 | 2 | PF00503 | |
| Domain | GproteinA_insert | 2.81e-03 | 16 | 93 | 2 | IPR011025 | |
| Domain | - | 2.81e-03 | 16 | 93 | 2 | 1.10.400.10 | |
| Domain | G_alpha | 2.81e-03 | 16 | 93 | 2 | SM00275 | |
| Domain | Gprotein_alpha_su | 3.18e-03 | 17 | 93 | 2 | IPR001019 | |
| Domain | Ig_V-set | 3.18e-03 | 199 | 93 | 5 | IPR013106 | |
| Domain | - | 3.96e-03 | 746 | 93 | 10 | 3.40.50.300 | |
| Domain | Apc4_WD40_dom | 4.40e-03 | 20 | 93 | 2 | IPR024977 | |
| Domain | ANAPC4_WD40 | 4.40e-03 | 20 | 93 | 2 | PF12894 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION_AMYLASE_ | 4.02e-10 | 9 | 73 | 5 | M47622 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 1.46e-09 | 11 | 73 | 5 | M1091 | |
| Pathway | REACTOME_DIGESTION | 1.01e-07 | 23 | 73 | 5 | M27790 | |
| Pathway | REACTOME_DIGESTION_AND_ABSORPTION | 2.90e-07 | 28 | 73 | 5 | M27837 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 6.97e-06 | 52 | 73 | 5 | M14171 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 7.32e-06 | 8 | 73 | 3 | MM14717 | |
| Pathway | REACTOME_DIGESTION | 1.66e-04 | 21 | 73 | 3 | MM15526 | |
| Pathway | REACTOME_DIGESTION_AND_ABSORPTION | 2.82e-04 | 25 | 73 | 3 | MM15557 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAI_AC_PKA_SIGNALING_PATHWAY | 3.18e-04 | 26 | 73 | 3 | M47553 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_COMPLEMENT_CASCADE_CFHR | 3.91e-04 | 6 | 73 | 2 | M47880 | |
| Pubmed | 8.18e-13 | 6 | 95 | 5 | 2452973 | ||
| Pubmed | The human alpha-amylase multigene family consists of haplotypes with variable numbers of genes. | 8.18e-13 | 6 | 95 | 5 | 2788608 | |
| Pubmed | 8.18e-13 | 6 | 95 | 5 | 15286789 | ||
| Pubmed | Regional assignment of human amylase (AMY) to p22----p21 of chromosome 1. | 8.18e-13 | 6 | 95 | 5 | 6608795 | |
| Pubmed | 8.18e-13 | 6 | 95 | 5 | 2081604 | ||
| Pubmed | 7.60e-12 | 8 | 95 | 5 | 12414807 | ||
| Pubmed | Low Copy Number of the AMY1 Locus Is Associated with Early-Onset Female Obesity in Finland. | 5.22e-11 | 4 | 95 | 4 | 26132294 | |
| Pubmed | Characterization of the amino termini of mouse salivary and pancreatic amylases. | 5.22e-11 | 4 | 95 | 4 | 6165618 | |
| Pubmed | Multiple polyadenylation sites in a mouse alpha-amylase gene. | 5.22e-11 | 4 | 95 | 4 | 6166922 | |
| Pubmed | Structural forms of the human amylase locus and their relationships to SNPs, haplotypes and obesity. | 5.22e-11 | 4 | 95 | 4 | 26098870 | |
| Pubmed | Electrophoretic variation of alpha-amylase in two inbred strains of Mus musculus. | 5.22e-11 | 4 | 95 | 4 | 4745489 | |
| Pubmed | Genetic variation in mouse salivary amylase rate of synthesis. | 5.22e-11 | 4 | 95 | 4 | 94264 | |
| Pubmed | 5.22e-11 | 4 | 95 | 4 | 3872721 | ||
| Pubmed | 5.22e-11 | 4 | 95 | 4 | 2476716 | ||
| Pubmed | A single mouse alpha-amylase gene specifies two different tissue-specific mRNAs. | 5.22e-11 | 4 | 95 | 4 | 6162570 | |
| Pubmed | Additional evidence for the close linkage of amy-1 and amy-2 in the mouse. | 5.22e-11 | 4 | 95 | 4 | 6163812 | |
| Pubmed | Members of the Amy-2 alpha-amylase gene family of mouse strain CE/J contain duplicated 5' termini. | 5.22e-11 | 4 | 95 | 4 | 2987507 | |
| Pubmed | 5.22e-11 | 4 | 95 | 4 | 6091898 | ||
| Pubmed | 5.22e-11 | 4 | 95 | 4 | 6176715 | ||
| Pubmed | Mouse liver and salivary gland alpha-amylase mRNAs differ only in 5' non-translated sequences. | 5.22e-11 | 4 | 95 | 4 | 6162108 | |
| Pubmed | 5.22e-11 | 4 | 95 | 4 | 16152770 | ||
| Pubmed | 5.22e-11 | 4 | 95 | 4 | 2423416 | ||
| Pubmed | 5.22e-11 | 4 | 95 | 4 | 6161122 | ||
| Pubmed | Expression of mouse Amy-2a alpha-amylase genes is regulated by strong pancreas-specific promoters. | 5.22e-11 | 4 | 95 | 4 | 3877171 | |
| Pubmed | Mouse alpha-amylase loci, Amy-1a and Amy-2a, are closely linked. | 5.22e-11 | 4 | 95 | 4 | 2989529 | |
| Pubmed | 5.22e-11 | 4 | 95 | 4 | 6160849 | ||
| Pubmed | Gentic polymorphism of amylase isoenzymes in feral populations of the house mouse. | 5.22e-11 | 4 | 95 | 4 | 1141004 | |
| Pubmed | 5.22e-11 | 4 | 95 | 4 | 6157477 | ||
| Pubmed | Simultaneous expression of salivary and pancreatic amylase genes in cultured mouse hepatoma cells. | 5.22e-11 | 4 | 95 | 4 | 2431276 | |
| Pubmed | Independent regulation of nonallelic pancreatic amylase genes in diabetic mice. | 5.22e-11 | 4 | 95 | 4 | 6207174 | |
| Pubmed | 5.22e-11 | 4 | 95 | 4 | 2410924 | ||
| Pubmed | Genetic regulation of GM4(NeuAc) expression in mouse erythrocytes. | 5.22e-11 | 4 | 95 | 4 | 2332419 | |
| Pubmed | 1.44e-10 | 54 | 95 | 7 | 8482578 | ||
| Pubmed | 1.73e-10 | 13 | 95 | 5 | 489953 | ||
| Pubmed | 2.61e-10 | 5 | 95 | 4 | 6529441 | ||
| Pubmed | 2.61e-10 | 5 | 95 | 4 | 6176569 | ||
| Pubmed | Murine Salivary Amylase Protects Against Streptococcus mutans-Induced Caries. | 2.61e-10 | 5 | 95 | 4 | 34276419 | |
| Pubmed | 2.61e-10 | 5 | 95 | 4 | 1348427 | ||
| Pubmed | Genetic mapping of the IL-12 alpha chain gene (Il12a) on mouse chromosome 3. | 2.61e-10 | 5 | 95 | 4 | 8661735 | |
| Pubmed | 7.80e-10 | 6 | 95 | 4 | 2002257 | ||
| Pubmed | 7.80e-10 | 6 | 95 | 4 | 2450406 | ||
| Pubmed | Ampd-2 maps to distal mouse chromosome 3 in linkage with Ampd-1. | 7.80e-10 | 6 | 95 | 4 | 2328996 | |
| Pubmed | Genetics of hydroxyacid oxidase isozymes in the mouse: localisation of Hao-2 on linkage group XVI. | 7.80e-10 | 6 | 95 | 4 | 284003 | |
| Pubmed | The mouse urate oxidase gene, Uox, maps to distal chromosome 3. | 7.80e-10 | 6 | 95 | 4 | 9250879 | |
| Pubmed | A fibrillar collagen gene, Col11a1, is essential for skeletal morphogenesis. | 7.80e-10 | 6 | 95 | 4 | 7859283 | |
| Pubmed | 7.80e-10 | 6 | 95 | 4 | 7946325 | ||
| Pubmed | Linkage of the cadmium resistance locus to loci on mouse chromosome 12. | 7.80e-10 | 6 | 95 | 4 | 1021597 | |
| Pubmed | Rostral cerebellar malformation, (rcm): a new recessive mutation on chromosome 3 of the mouse. | 1.82e-09 | 7 | 95 | 4 | 1401878 | |
| Pubmed | Analysis of the mouse Amy locus in recombinant inbred mouse strains. | 1.82e-09 | 7 | 95 | 4 | 2451911 | |
| Pubmed | 1.82e-09 | 7 | 95 | 4 | 7949740 | ||
| Pubmed | 1.82e-09 | 7 | 95 | 4 | 6160178 | ||
| Pubmed | 1.82e-09 | 7 | 95 | 4 | 8604219 | ||
| Pubmed | 1.82e-09 | 7 | 95 | 4 | 8666240 | ||
| Pubmed | 3.63e-09 | 8 | 95 | 4 | 2040456 | ||
| Pubmed | 3.63e-09 | 8 | 95 | 4 | 3038891 | ||
| Pubmed | 3.63e-09 | 8 | 95 | 4 | 8486361 | ||
| Pubmed | Murine VCAM-1. Molecular cloning, mapping, and analysis of a truncated form. | 3.63e-09 | 8 | 95 | 4 | 7523515 | |
| Pubmed | 3.63e-09 | 8 | 95 | 4 | 2824476 | ||
| Pubmed | Linkage relationships among eleven biochemical loci in Peromyscus. | 3.63e-09 | 8 | 95 | 4 | 6200103 | |
| Pubmed | Evolution of the mammalian G protein alpha subunit multigene family. | 4.50e-09 | 49 | 95 | 6 | 1302014 | |
| Pubmed | 6.51e-09 | 9 | 95 | 4 | 93520 | ||
| Pubmed | 1.08e-08 | 10 | 95 | 4 | 9121556 | ||
| Pubmed | 1.08e-08 | 10 | 95 | 4 | 2897103 | ||
| Pubmed | 1.70e-08 | 11 | 95 | 4 | 23449223 | ||
| Pubmed | FGF10 acts as a major ligand for FGF receptor 2 IIIb in mouse multi-organ development. | 1.70e-08 | 11 | 95 | 4 | 11062007 | |
| Pubmed | 1.70e-08 | 11 | 95 | 4 | 7608209 | ||
| Pubmed | 1.70e-08 | 11 | 95 | 4 | 1617215 | ||
| Pubmed | 1.70e-08 | 11 | 95 | 4 | 2903254 | ||
| Pubmed | 1.70e-08 | 11 | 95 | 4 | 2565740 | ||
| Pubmed | Mouse R-cadherin: expression during the organogenesis of pancreas and gastrointestinal tract. | 1.70e-08 | 11 | 95 | 4 | 7493641 | |
| Pubmed | Four loci from human chromosome 1 are physically assigned to sheep chromosome 1p. | 1.70e-08 | 11 | 95 | 4 | 8589528 | |
| Pubmed | 1.97e-08 | 3 | 95 | 3 | 32697825 | ||
| Pubmed | The structure of two distinct pancreatic amylase genes in mouse strain YBR. | 1.97e-08 | 3 | 95 | 3 | 2413838 | |
| Pubmed | 1.97e-08 | 3 | 95 | 3 | 6176528 | ||
| Pubmed | State and trait variance in salivary α-amylase: a behavioral genetic study. | 1.97e-08 | 3 | 95 | 3 | 21827821 | |
| Pubmed | Report of the Committee on the Genetic Constitution of Chromosome 1. | 1.97e-08 | 3 | 95 | 3 | 6360562 | |
| Pubmed | Tissue-specific and insulin-dependent expression of a pancreatic amylase gene in transgenic mice. | 1.97e-08 | 3 | 95 | 3 | 2436036 | |
| Pubmed | Two distinct pancreatic amylase genes are active in YBR mice. | 1.97e-08 | 3 | 95 | 3 | 6180955 | |
| Pubmed | Comparative genomic analysis of the mouse and rat amylase multigene family. | 1.97e-08 | 3 | 95 | 3 | 17223109 | |
| Pubmed | 1.97e-08 | 3 | 95 | 3 | 15299664 | ||
| Pubmed | 1.97e-08 | 3 | 95 | 3 | 8413315 | ||
| Pubmed | 1.97e-08 | 3 | 95 | 3 | 22063648 | ||
| Pubmed | An insulin-responsive element in the pancreatic enhancer of the amylase gene. | 1.97e-08 | 3 | 95 | 3 | 7678001 | |
| Pubmed | 1.97e-08 | 3 | 95 | 3 | 6098446 | ||
| Pubmed | 1.97e-08 | 3 | 95 | 3 | 30982860 | ||
| Pubmed | 1.97e-08 | 3 | 95 | 3 | 1699843 | ||
| Pubmed | 1.97e-08 | 3 | 95 | 3 | 12527308 | ||
| Pubmed | 1.97e-08 | 3 | 95 | 3 | 2414282 | ||
| Pubmed | 1.97e-08 | 3 | 95 | 3 | 28659346 | ||
| Pubmed | 1.97e-08 | 3 | 95 | 3 | 25588701 | ||
| Pubmed | 2.54e-08 | 12 | 95 | 4 | 8144363 | ||
| Pubmed | Assignment of the mouse homologues of 6 loci from HSA1p to chromosomes 3 and 4. | 3.66e-08 | 13 | 95 | 4 | 7829080 | |
| Pubmed | 5.12e-08 | 14 | 95 | 4 | 2902233 | ||
| Pubmed | 5.12e-08 | 14 | 95 | 4 | 7894156 | ||
| Pubmed | Syntenic assignment of human chromosome 1 homologous loci in the bovine. | 5.12e-08 | 14 | 95 | 4 | 8001974 | |
| Pubmed | 7.88e-08 | 4 | 95 | 3 | 2458567 | ||
| Pubmed | 7.88e-08 | 4 | 95 | 3 | 20939500 | ||
| Pubmed | Expression of sulfated gp300 and changes in glycosylation during pancreatic development. | 7.88e-08 | 4 | 95 | 3 | 8543783 | |
| Pubmed | An amylase/Cre transgene marks the whole endoderm but the primordia of liver and ventral pancreas. | 7.88e-08 | 4 | 95 | 3 | 16786601 | |
| Pubmed | 9.27e-08 | 16 | 95 | 4 | 2571572 | ||
| Interaction | HTN3 interactions | 1.11e-05 | 30 | 94 | 4 | int:HTN3 | |
| Interaction | AMY2B interactions | 1.15e-05 | 10 | 94 | 3 | int:AMY2B | |
| Cytoband | 1p21 | 1.41e-09 | 24 | 95 | 5 | 1p21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p21 | 3.07e-06 | 107 | 95 | 5 | chr1p21 | |
| Cytoband | 15q22 | 1.66e-03 | 29 | 95 | 2 | 15q22 | |
| Cytoband | 1q23.2 | 2.41e-03 | 35 | 95 | 2 | 1q23.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q22 | 2.65e-03 | 132 | 95 | 3 | chr15q22 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.31e-08 | 161 | 71 | 9 | 593 | |
| GeneFamily | Immunoglobulin like domain containing | 9.69e-04 | 193 | 71 | 5 | 594 | |
| Coexpression | LEE_AGING_MUSCLE_UP | 3.80e-07 | 41 | 95 | 5 | MM698 | |
| Coexpression | BERGER_MBD2_TARGETS | 7.45e-06 | 11 | 95 | 3 | MM905 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA1_UP | 1.38e-05 | 143 | 95 | 6 | MM1056 | |
| Coexpression | NABA_MATRISOME | PLXNA3 HSPG2 CLEC9A HMCN1 COL26A1 CILP ADAMTS9 SULF1 PRG2 MMP23B ADAMTS17 IL17F TNFSF15 FREM1 | 1.59e-05 | 1008 | 95 | 14 | MM17056 |
| Coexpression | NABA_MATRISOME | PLXNA3 HSPG2 CLEC9A HMCN1 COL26A1 CILP ADAMTS9 SULF1 PRG2 MMP23B ADAMTS17 IL17F TNFSF15 FREM1 | 1.94e-05 | 1026 | 95 | 14 | M5889 |
| Coexpression | CAIRO_LIVER_DEVELOPMENT_DN | 2.68e-05 | 239 | 95 | 7 | MM1274 | |
| Coexpression | CADWELL_ATG16L1_TARGETS_UP | 6.57e-05 | 116 | 95 | 5 | MM1240 | |
| Coexpression | MCCLUNG_CREB1_TARGETS_DN | 6.76e-05 | 60 | 95 | 4 | MM654 | |
| Coexpression | PGF_UP.V1_DN | 6.82e-05 | 190 | 95 | 6 | M2673 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-06 | 160 | 95 | 6 | 8590281165eab6514a9f6a022b900d4c222c1044 | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell|Adult / Lineage, Cell type, age group and donor | 1.58e-06 | 167 | 95 | 6 | d584a8548a5317bd9686b3be8246ae6ed568796b | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.81e-06 | 171 | 95 | 6 | 121e63ca281ad765d76c2afb3b4d441329b47f81 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-06 | 178 | 95 | 6 | 6d9ecfaeb50d562899380de379ebf7b99fd8adc9 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-06 | 178 | 95 | 6 | d3f518cd75b02e85d45cbb9b2eff30f0272512a8 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.44e-06 | 180 | 95 | 6 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.14e-06 | 188 | 95 | 6 | 6c6486cae9a8f2f8200598cb4bfd3fd513eb28a3 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.23e-06 | 189 | 95 | 6 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.54e-06 | 192 | 95 | 6 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-B_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.76e-06 | 194 | 95 | 6 | 582db7f7fa9aa08027ae18ed607945b5d1dc908a | |
| ToppCell | 343B-Endothelial_cells-Endothelial-B_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.76e-06 | 194 | 95 | 6 | bda89111386398a072b70e8153b2a762298a047a | |
| ToppCell | IPF-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 3.99e-06 | 196 | 95 | 6 | 7fc9894ceb79dab9f0495acc84e2d6d0d1c69bb7 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.11e-06 | 197 | 95 | 6 | 26475b9e4d6bfc0ae818dea13d139888ed7e92f1 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.11e-06 | 197 | 95 | 6 | 155e63b33302a87393ace699b2f6d73abe9c5763 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.48e-06 | 200 | 95 | 6 | ad3fb8ef0be45032369d1325024787fbe1dfb8d6 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.48e-06 | 200 | 95 | 6 | 54806080b5e97859ee6a4a9b4f19e22021c218f5 | |
| ToppCell | 21-Trachea-Epithelial-Submucosal_gland_basal|Trachea / Age, Tissue, Lineage and Cell class | 2.32e-05 | 159 | 95 | 5 | 4f670b57b8d3b090ea2f1aafe15baf93cb7ef146 | |
| ToppCell | Children_(3_yrs)-Immune-dendritic_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.54e-05 | 162 | 95 | 5 | 86a0b9dabd150dc993bfc0f3344804de7f8e4042 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.69e-05 | 164 | 95 | 5 | e5258efd6765acfc394708f697ec76acaef09079 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Stem_cells-neuroepithelial-like_cells|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 2.94e-05 | 167 | 95 | 5 | e488d9c7cf4355959e3833de3bd496c13fc11b1b | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.20e-05 | 170 | 95 | 5 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.29e-05 | 171 | 95 | 5 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | 3'-Adult-Appendix-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.77e-05 | 176 | 95 | 5 | 30adf8f1638c6244586f8101c2590bb964dfae00 | |
| ToppCell | 3'-Adult-Appendix-Epithelial-mature_enterocytic-Colonocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.77e-05 | 176 | 95 | 5 | 23fa02d4c39e0b8faa1658116d50b6233a952ccc | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.87e-05 | 177 | 95 | 5 | 8abdf1d970b2f15e17e185f3e612dd5065c88757 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.98e-05 | 178 | 95 | 5 | 4df6218b20c2f076c22346d23260964cc0d73e65 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.20e-05 | 180 | 95 | 5 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.31e-05 | 181 | 95 | 5 | 9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9 | |
| ToppCell | Control-Myeloid-DC1|Control / Condition, Lineage and Cell class | 4.31e-05 | 181 | 95 | 5 | 5a2a1f017ad23baed9972c68b4a46f4c618ef21a | |
| ToppCell | Control_saline-Hematopoietic_Myeloid-Dendritic_cells-mDC|Control_saline / Treatment groups by lineage, cell group, cell type | 4.31e-05 | 181 | 95 | 5 | 818ac31a718e9b29feb4c4eecbc339e6af45254a | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-Bergmann_glial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.54e-05 | 183 | 95 | 5 | 25c96df8ea0c7bbedbb7699ee84ad6234d19cba8 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.66e-05 | 184 | 95 | 5 | d754c3de621429b220ae4ac426cdfc619e848462 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.78e-05 | 185 | 95 | 5 | dbbd348714cd16a4948a04648e914b1e71e2a8ef | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.78e-05 | 185 | 95 | 5 | bea69058afa5aa927fe15c1f8d46460562ec4dd4 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.78e-05 | 185 | 95 | 5 | 785c55d39909fac74415f24427979691e7e694e6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.78e-05 | 185 | 95 | 5 | 97a1dcacbc48dc3f41c26fbb59af35c935f894d4 | |
| ToppCell | 10x5'v1-week_12-13-Endothelial-stroma-sinusoidal_EC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.91e-05 | 186 | 95 | 5 | e8ead5634686ebaa6a230eea69795d923ce9939d | |
| ToppCell | (8)_CD34_progenitor|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 4.91e-05 | 186 | 95 | 5 | 943c604a7cd873faf510096d094100512ba2d6bc | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.91e-05 | 186 | 95 | 5 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.91e-05 | 186 | 95 | 5 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.91e-05 | 186 | 95 | 5 | 7c1807fca590cdccf7f5734460bac228d33964ca | |
| ToppCell | (8)_CD34_progenitor|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 4.91e-05 | 186 | 95 | 5 | e69a986b8618effd61875fda528a2e44aab11868 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 5.03e-05 | 187 | 95 | 5 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC3-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.03e-05 | 187 | 95 | 5 | 3d4e81183cb7f6522ae654ddac494662402aa86d | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.03e-05 | 187 | 95 | 5 | a9316e2818217ec5feae9cf8816f7249803caee6 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.03e-05 | 187 | 95 | 5 | 13731298bc562ec29582f5da1b4c97261284f6f1 | |
| ToppCell | Control-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 5.03e-05 | 187 | 95 | 5 | 5429ae85942b8ec3895cceb63c663de3c24ca064 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.16e-05 | 188 | 95 | 5 | de6f4889e0c5f39fbbaefd85526f645c6afa09d5 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.29e-05 | 189 | 95 | 5 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.29e-05 | 189 | 95 | 5 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-05 | 189 | 95 | 5 | 29287525120be2953b76881ba3cfc4379c265e7a | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-05 | 189 | 95 | 5 | 7150dad9a92a715487c2d8130fa01b752ea69663 | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-05 | 189 | 95 | 5 | 6e4c0effd5192fd00052abc048fdb87a74fb6554 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.29e-05 | 189 | 95 | 5 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.43e-05 | 190 | 95 | 5 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | Fibroblasts-CD55+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 5.43e-05 | 190 | 95 | 5 | b4088128f5acf53f43244c9af9fe44e033f1a57a | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.43e-05 | 190 | 95 | 5 | 71e112dfb8c3190fe0286b45a046ea789eb6a8db | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 5.43e-05 | 190 | 95 | 5 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.43e-05 | 190 | 95 | 5 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.56e-05 | 191 | 95 | 5 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.56e-05 | 191 | 95 | 5 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.56e-05 | 191 | 95 | 5 | 4b50fdd310701251e64e16cd2d07ce03dbfd3e3e | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.56e-05 | 191 | 95 | 5 | 75d2197076a9dfc868e8baf95bd4c5e44f438e3e | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.56e-05 | 191 | 95 | 5 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.70e-05 | 192 | 95 | 5 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.70e-05 | 192 | 95 | 5 | 72881b280a415e65f87a80ca1369cbb0b722a0c4 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.70e-05 | 192 | 95 | 5 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.70e-05 | 192 | 95 | 5 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.70e-05 | 192 | 95 | 5 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.70e-05 | 192 | 95 | 5 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.70e-05 | 192 | 95 | 5 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.70e-05 | 192 | 95 | 5 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.70e-05 | 192 | 95 | 5 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.70e-05 | 192 | 95 | 5 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.84e-05 | 193 | 95 | 5 | 9d0b966d13cbce97beb43de6dc77f006c363a181 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.84e-05 | 193 | 95 | 5 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.84e-05 | 193 | 95 | 5 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.84e-05 | 193 | 95 | 5 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-T_&_ILC-Cycling_T|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.84e-05 | 193 | 95 | 5 | bec113472c40c0106a9427248cbcf54548797596 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.84e-05 | 193 | 95 | 5 | cf3cbf79ccd34ddcf06ec6194a18a7afd7f91f39 | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 5.99e-05 | 194 | 95 | 5 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.99e-05 | 194 | 95 | 5 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.99e-05 | 194 | 95 | 5 | 69362e13158033de44f90f3773db6c0f27de8cb3 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.99e-05 | 194 | 95 | 5 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | (5)_Fibroblast-C_(Myofibroblast)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.99e-05 | 194 | 95 | 5 | 29a72e565c19407bbd198cfbc2a78106fe830d05 | |
| ToppCell | PND07-28-samps-Mesenchymal|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 5.99e-05 | 194 | 95 | 5 | 68bcc1fe8dc8d5f23a12154fc9b41362fdef0b1d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.99e-05 | 194 | 95 | 5 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 6.14e-05 | 195 | 95 | 5 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.14e-05 | 195 | 95 | 5 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 6.14e-05 | 195 | 95 | 5 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | 10x5'|World / Manually curated celltypes from each tissue | 6.14e-05 | 195 | 95 | 5 | de28b998793271c4f69ce9e183c3e62d809e9cc8 | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Mac-Intestinal_macrophages|GI_small-bowel / Manually curated celltypes from each tissue | 6.29e-05 | 196 | 95 | 5 | 075e5746fa5cb121115a1d51b823c0fbf8d54305 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Ionocyte_n_Brush|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.29e-05 | 196 | 95 | 5 | ef650ff106a76c1e926e13c7f002fbc452cc48ae | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.29e-05 | 196 | 95 | 5 | 22538376a95fe3afe8639a216a5497087aa94110 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 6.29e-05 | 196 | 95 | 5 | 275e153347caf94edc0c50021bbab49c8696fecb | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 6.44e-05 | 197 | 95 | 5 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.44e-05 | 197 | 95 | 5 | 71786e9432e2d649f5d86f639abb25e7102deb67 | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 6.60e-05 | 198 | 95 | 5 | 4f4632f26a2043c5e4ab89031b4229b5dca1bd48 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.60e-05 | 198 | 95 | 5 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.60e-05 | 198 | 95 | 5 | a4005a49cf6709b543994ceb51ecd5dc46197fa9 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.19e-04 | 50 | 55 | 4 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4 | |
| Drug | actinidine | 1.14e-12 | 5 | 95 | 5 | CID000068231 | |
| Drug | R 623 | 6.80e-12 | 6 | 95 | 5 | CID003027594 | |
| Drug | 4,6-O-3-ketobutylidene maltopentaose | 6.80e-12 | 6 | 95 | 5 | CID003083414 | |
| Drug | dimethylaminomethylferrocene | 6.80e-12 | 6 | 95 | 5 | CID000102082 | |
| Drug | mono-6-deoxy-6-fluorocyclomaltoheptaose | 6.80e-12 | 6 | 95 | 5 | CID000127364 | |
| Drug | CNP-G3 | 6.80e-12 | 6 | 95 | 5 | CID003082910 | |
| Drug | AC1OAGH8 | 6.80e-12 | 6 | 95 | 5 | CID006857368 | |
| Drug | AC1L5BOU | 2.37e-11 | 7 | 95 | 5 | CID000174858 | |
| Drug | methyl blue | 2.37e-11 | 7 | 95 | 5 | CID011969534 | |
| Drug | BG5P | 2.37e-11 | 7 | 95 | 5 | CID003082752 | |
| Drug | N-vinylcaprolactam | 6.30e-11 | 8 | 95 | 5 | CID000075227 | |
| Drug | desethylaprophen | 6.30e-11 | 8 | 95 | 5 | CID000163919 | |
| Drug | azintamide | 6.30e-11 | 8 | 95 | 5 | CID000071105 | |
| Drug | AC1LA2MZ | 1.10e-10 | 58 | 95 | 8 | CID000460551 | |
| Drug | alpha-maltosyl fluoride | 1.41e-10 | 9 | 95 | 5 | CID000194237 | |
| Drug | trestatin A | 1.41e-10 | 9 | 95 | 5 | CID003054994 | |
| Drug | Sudan black B | 2.49e-10 | 64 | 95 | 8 | CID000061336 | |
| Drug | AC1LAC07 | 2.82e-10 | 10 | 95 | 5 | CID000485275 | |
| Drug | Glc)4 | 2.82e-10 | 10 | 95 | 5 | CID000189098 | |
| Drug | Ro 20-0083 | 2.82e-10 | 10 | 95 | 5 | CID003082332 | |
| Drug | AC1L3M0Q | 2.82e-10 | 10 | 95 | 5 | CID000118008 | |
| Drug | N-PMT | 2.84e-10 | 4 | 95 | 4 | CID000194224 | |
| Drug | AC1MQT4V | 2.84e-10 | 4 | 95 | 4 | CID003482066 | |
| Drug | SAIB-SG | 2.84e-10 | 4 | 95 | 4 | CID002735139 | |
| Drug | 2-nitropropyl acetate | 2.84e-10 | 4 | 95 | 4 | CID013573844 | |
| Drug | Dembrexine | 2.84e-10 | 4 | 95 | 4 | CID000072009 | |
| Drug | g lw | 2.84e-10 | 4 | 95 | 4 | CID000444139 | |
| Drug | beta-santalene | 2.84e-10 | 4 | 95 | 4 | CID000010534 | |
| Drug | hematoxilina | SLC5A5 AMY1A AMY1B AMY1C AMY2A AMY2B CEACAM5 MMP23B NCAM1 ZNF654 TG | 2.91e-10 | 183 | 95 | 11 | CID000010603 |
| Drug | validamycin D | 5.15e-10 | 11 | 95 | 5 | CID000166726 | |
| Drug | FG5P | 5.15e-10 | 11 | 95 | 5 | CID000127486 | |
| Drug | CNP-G5 | 5.15e-10 | 11 | 95 | 5 | CID000127309 | |
| Drug | HgI2 | 5.15e-10 | 11 | 95 | 5 | CID000024485 | |
| Drug | 2C KM | 5.15e-10 | 11 | 95 | 5 | CID009549196 | |
| Drug | chitosan | 8.80e-10 | 12 | 95 | 5 | CID000071853 | |
| Drug | azaprophen | 8.80e-10 | 12 | 95 | 5 | CID000129486 | |
| Drug | Deposiston | 1.42e-09 | 5 | 95 | 4 | CID003080829 | |
| Drug | 2-[[(2-amino-1,3-thiazol-4-yl)-(2-oxoethylcarbamoyl)methylidene]amino]oxy-2-methyl-propanoic Acid | 1.42e-09 | 5 | 95 | 4 | CID010358258 | |
| Drug | lunularic acid | 1.42e-09 | 5 | 95 | 4 | CID000161413 | |
| Drug | himachalene | 1.42e-09 | 5 | 95 | 4 | CID000015095 | |
| Drug | 2TAA | 1.42e-09 | 5 | 95 | 4 | CID000127374 | |
| Drug | cimicifugic acid A | 1.42e-09 | 5 | 95 | 4 | CID006449879 | |
| Drug | silver perchlorate | 1.42e-09 | 5 | 95 | 4 | CID000024562 | |
| Drug | AC1L4DZ4 | 1.42e-09 | 5 | 95 | 4 | CID000155287 | |
| Drug | methyl 1'-epiacarviosin | 1.43e-09 | 13 | 95 | 5 | CID000197426 | |
| Drug | isoacarbose | 1.43e-09 | 13 | 95 | 5 | CID000449165 | |
| Drug | maltal | 1.43e-09 | 13 | 95 | 5 | CID000169427 | |
| Drug | Cyclodextrins | 2.21e-09 | 14 | 95 | 5 | CID000024238 | |
| Drug | 2-chloro-4-nitrophenol | 2.21e-09 | 14 | 95 | 5 | CID000012074 | |
| Drug | terephthaloyl chloride | 2.21e-09 | 14 | 95 | 5 | CID000007488 | |
| Drug | 2C5P | 3.08e-09 | 127 | 95 | 9 | CID000447961 | |
| Drug | 4-nitrophenylmaltoheptaoside | 3.30e-09 | 15 | 95 | 5 | CID000173254 | |
| Drug | 2-amino-6-picoline | 4.24e-09 | 6 | 95 | 4 | CID000015765 | |
| Drug | phenol blue | 4.24e-09 | 6 | 95 | 4 | CID000075078 | |
| Drug | Gu-4 | 4.24e-09 | 6 | 95 | 4 | CID000448679 | |
| Drug | Borane dimethylamine complex | 4.24e-09 | 6 | 95 | 4 | CID009898794 | |
| Drug | AC1L3OV4 | 4.24e-09 | 6 | 95 | 4 | CID000092801 | |
| Drug | (2S)-2-acetamido-3-[(3E)-3-[(4-arsonophenyl)hydrazono]-4-oxo-cyclohexa-1,5-dien-1-yl]propanoic acid | 4.24e-09 | 6 | 95 | 4 | CID009577343 | |
| Drug | vermella | 4.24e-09 | 6 | 95 | 4 | CID000203726 | |
| Drug | hymenin | 4.24e-09 | 6 | 95 | 4 | CID000010499 | |
| Drug | mercuric thiocyanate | 4.24e-09 | 6 | 95 | 4 | CID000011615 | |
| Drug | gamma-cyclodextrin | 4.79e-09 | 16 | 95 | 5 | CID000086575 | |
| Drug | Bay e 4609 | 4.79e-09 | 16 | 95 | 5 | CID003085308 | |
| Drug | potassium periodate | 4.79e-09 | 16 | 95 | 5 | CID000516896 | |
| Drug | uranyl acetate | 7.92e-09 | 36 | 95 | 6 | CID000010915 | |
| Drug | trimitan | 9.33e-09 | 18 | 95 | 5 | CID000005561 | |
| Drug | aprophen | 9.33e-09 | 18 | 95 | 5 | CID000071128 | |
| Drug | 3KBG5CNP | 9.86e-09 | 7 | 95 | 4 | CID003083250 | |
| Drug | AC1L9UU3 | 9.86e-09 | 7 | 95 | 4 | CID000071762 | |
| Drug | Paramax | 9.86e-09 | 7 | 95 | 4 | CID000156411 | |
| Drug | amino-methyl | 9.86e-09 | 7 | 95 | 4 | CID000142005 | |
| Drug | boric acid gel | 1.97e-08 | 8 | 95 | 4 | CID003016474 | |
| Drug | AC1NSVJM | 1.97e-08 | 8 | 95 | 4 | CID005317411 | |
| Drug | 9-azidoacridine | 1.97e-08 | 8 | 95 | 4 | CID000146692 | |
| Drug | acrinor | 1.97e-08 | 8 | 95 | 4 | CID005489637 | |
| Drug | NSC300622 | 1.97e-08 | 8 | 95 | 4 | CID000028426 | |
| Drug | theodrenaline | 1.97e-08 | 8 | 95 | 4 | CID000071857 | |
| Drug | rhodanile blue | 1.97e-08 | 8 | 95 | 4 | CID000073372 | |
| Drug | AC1L3XPY | 2.19e-08 | 21 | 95 | 5 | CID000124005 | |
| Drug | potassium thiocyanate solution | 2.19e-08 | 21 | 95 | 5 | CID010931372 | |
| Drug | Bz-C | 2.83e-08 | 22 | 95 | 5 | CID000001511 | |
| Drug | maltosaccharide | 2.83e-08 | 22 | 95 | 5 | CID005461034 | |
| Drug | GSAD | 3.53e-08 | 9 | 95 | 4 | CID009909127 | |
| Drug | GU-3 | 3.53e-08 | 9 | 95 | 4 | CID000448687 | |
| Drug | zingiberene | 3.53e-08 | 9 | 95 | 4 | CID000092776 | |
| Drug | Atonik | 3.53e-08 | 9 | 95 | 4 | CID000069471 | |
| Drug | H 187 | 3.53e-08 | 9 | 95 | 4 | CID000001742 | |
| Drug | mercuric nitrate | 3.53e-08 | 9 | 95 | 4 | CID000024864 | |
| Drug | Panose B | 4.54e-08 | 24 | 95 | 5 | CID000439297 | |
| Drug | CID439354 | 5.65e-08 | 25 | 95 | 5 | CID000439354 | |
| Drug | I ZE | 5.86e-08 | 10 | 95 | 4 | CID009549200 | |
| Drug | trans-cinnamamide | 5.86e-08 | 10 | 95 | 4 | CID000012135 | |
| Drug | CG-120 | 5.86e-08 | 10 | 95 | 4 | CID000171403 | |
| Drug | eicosa-11,14-dienoic acid | 5.86e-08 | 10 | 95 | 4 | CID000003208 | |
| Drug | UDP-pyridoxal | 5.86e-08 | 10 | 95 | 4 | CID000126789 | |
| Drug | naphthalene-1,3,6,8-tetrol | 5.86e-08 | 10 | 95 | 4 | CID000440202 | |
| Drug | AC1N3UXZ | 7.04e-08 | 3 | 95 | 3 | CID004118625 | |
| Drug | pentylamine | 8.81e-08 | 53 | 95 | 6 | CID000008060 | |
| Drug | Tempamine | 9.18e-08 | 11 | 95 | 4 | CID000550942 | |
| Drug | L-tert-leucine | 9.18e-08 | 11 | 95 | 4 | CID000164608 | |
| Disease | alpha-amylase 1 measurement | 1.25e-08 | 9 | 95 | 4 | EFO_0801371 | |
| Disease | age related macular degeneration 1 (is_implicated_in) | 6.13e-05 | 4 | 95 | 2 | DOID:0110014 (is_implicated_in) | |
| Disease | Macular Degeneration, Age-Related, 1 | 6.13e-05 | 4 | 95 | 2 | C1864205 | |
| Disease | MACULAR DEGENERATION, AGE-RELATED, 1 | 6.13e-05 | 4 | 95 | 2 | 603075 | |
| Disease | Age related macular degeneration 1 | 6.13e-05 | 4 | 95 | 2 | cv:C1864205 | |
| Disease | bacterial infectious disease (implicated_via_orthology) | 1.02e-04 | 5 | 95 | 2 | DOID:104 (implicated_via_orthology) | |
| Disease | Age related macular degeneration | 1.23e-04 | 30 | 95 | 3 | C0242383 | |
| Disease | Thyroid Dyshormonogenesis 1 | 1.53e-04 | 6 | 95 | 2 | C1848805 | |
| Disease | Goiter | 2.13e-04 | 7 | 95 | 2 | C0018021 | |
| Disease | McCune Albright syndrome (implicated_via_orthology) | 2.84e-04 | 8 | 95 | 2 | DOID:1858 (implicated_via_orthology) | |
| Disease | C3 glomerulopathy | 3.64e-04 | 9 | 95 | 2 | C4087273 | |
| Disease | disease progression measurement | 1.02e-03 | 61 | 95 | 3 | EFO_0008336 | |
| Disease | ascending aortic diameter | 1.11e-03 | 140 | 95 | 4 | EFO_0021787 | |
| Disease | mean arterial pressure | 1.16e-03 | 499 | 95 | 7 | EFO_0006340 | |
| Disease | Keratoderma, Palmoplantar | 1.20e-03 | 16 | 95 | 2 | C4551675 | |
| Disease | Trigonocephaly | 1.20e-03 | 16 | 95 | 2 | C0265535 | |
| Disease | Scaphycephaly | 1.20e-03 | 16 | 95 | 2 | C0265534 | |
| Disease | Synostotic Posterior Plagiocephaly | 1.20e-03 | 16 | 95 | 2 | C1833340 | |
| Disease | gastroparesis | 1.20e-03 | 16 | 95 | 2 | EFO_1000948 | |
| Disease | Synostotic Anterior Plagiocephaly | 1.20e-03 | 16 | 95 | 2 | C2931150 | |
| Disease | Metopic synostosis | 1.20e-03 | 16 | 95 | 2 | C1860819 | |
| Disease | Craniosynostosis, Type 1 | 1.20e-03 | 16 | 95 | 2 | C4551902 | |
| Disease | Acrocephaly | 1.20e-03 | 16 | 95 | 2 | C0030044 | |
| Disease | susceptibility to vaginal yeast infection measurement | 1.22e-03 | 65 | 95 | 3 | EFO_0008412 | |
| Disease | Brachycephaly | 1.35e-03 | 17 | 95 | 2 | C0221356 | |
| Disease | Age-related macular degeneration | 1.52e-03 | 18 | 95 | 2 | cv:C0242383 | |
| Disease | migraine disorder, systolic blood pressure | 1.52e-03 | 18 | 95 | 2 | EFO_0006335, MONDO_0005277 | |
| Disease | Unipolar Depression | 1.53e-03 | 259 | 95 | 5 | C0041696 | |
| Disease | juvenile idiopathic arthritis | 1.78e-03 | 74 | 95 | 3 | EFO_0002609 | |
| Disease | Craniosynostosis | 1.88e-03 | 20 | 95 | 2 | C0010278 | |
| Disease | Disproportionate short stature | 1.99e-03 | 77 | 95 | 3 | C0878659 | |
| Disease | CCL24 measurement | 2.27e-03 | 22 | 95 | 2 | EFO_0009418 | |
| Disease | Graves disease | 2.30e-03 | 81 | 95 | 3 | EFO_0004237 | |
| Disease | frailty measurement | 2.48e-03 | 23 | 95 | 2 | EFO_0009885 | |
| Disease | carpal tunnel syndrome | 3.01e-03 | 89 | 95 | 3 | EFO_0004143 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VSQLRAQGEACVQFQ | 56 | O95150 | |
| ENANVLARYASICQQ | 166 | P09972 | |
| ENANVLARYASICQQ | 166 | P04075 | |
| VTRNDARAYVCGIQN | 561 | P06731 | |
| DNNRIRQVVSIYGSC | 541 | O75843 | |
| CNNVGVRIYVDAVIN | 101 | P0DTE7 | |
| CNNVGVRIYVDAVIN | 101 | P0DTE8 | |
| CREQQCGSVNSYRVL | 316 | P06127 | |
| CNNVGVRIYVDAVIN | 101 | P0DUB6 | |
| QQLVCFRQAGNARVT | 2796 | Q8TDJ6 | |
| QVLAANTYQLECRGV | 1226 | O95622 | |
| CNNVGVRIYVDAVIN | 101 | P19961 | |
| RQCYQEVCNDRINAN | 1021 | Q8TE56 | |
| CYTQLRDNRNAARNN | 11 | Q5JR59 | |
| PRVAQQDSGQYICNA | 3266 | P98160 | |
| VRICFQASYRDQQGQ | 266 | Q01201 | |
| VQACFNRSREYQLND | 136 | P63096 | |
| CNVQQGNVRETYRYL | 31 | Q92806 | |
| AEQVTYQRNRFGAQQ | 841 | P49736 | |
| CNNVGVRIYVDAVIN | 101 | P04746 | |
| TEGRYCVQLSQIQAQ | 396 | P13645 | |
| RNRCQNRDVRQYVQG | 131 | P61626 | |
| YQCTARNERGAAVSN | 121 | Q92823 | |
| GDAQQLSQVNCSERY | 66 | Q6PRD1 | |
| ASVCDYLEQQVARGN | 126 | Q86UW9 | |
| YQACVREANARQQDL | 271 | Q9P107 | |
| QYSLQQTCVFNRLEG | 3461 | Q15751 | |
| RGLARVADNAQQQYV | 506 | Q8TDD1 | |
| QQVQQVAAEYCRACR | 181 | P17844 | |
| FRQCQGDRVIYTNNQ | 116 | Q9BX97 | |
| QKNYECVVRVQGRQQ | 716 | P51805 | |
| AVDVVLENGSQYRCQ | 1086 | Q9UHC1 | |
| QIICNTGYRLQNNEN | 111 | P36980 | |
| TGYRLQNNENNISCV | 116 | P36980 | |
| LYQLEGNNQITCRNG | 181 | P36980 | |
| NAAAQACREQYLGNL | 2076 | Q5H8C1 | |
| QQAVQAAFGDQCRII | 491 | O43301 | |
| QDGENQSVYQNLCRE | 501 | P18084 | |
| DCAANQQVTYRISGV | 76 | Q02413 | |
| AIYCQRCVERTQQNG | 1081 | Q8IVE3 | |
| NRYPSEVVQAQCRNL | 91 | Q96PD4 | |
| VDLSNVCAQYRQVRF | 911 | O75694 | |
| VIAQAQVSNTGLYRC | 1791 | Q96RW7 | |
| HQCRYNQICENTRGS | 5281 | Q96RW7 | |
| VQDNALQRVSRCYRQ | 1176 | O95248 | |
| HCGEQNLTVVQYRSN | 331 | Q9NQX0 | |
| RLVVQQACQADTGEY | 1406 | Q5VST9 | |
| ARNRQNCALLEQAYA | 5851 | Q5VST9 | |
| INYRIQCSVSALNQG | 141 | P13727 | |
| GNVVFGLYDCQTRQN | 66 | A4D1B5 | |
| RVVVCQDENGYTAND | 1351 | Q9P2N4 | |
| TACQAVQHQRGRRQY | 86 | Q8TF46 | |
| YGCNRGQIQSLQQSA | 741 | O75417 | |
| SRRNAFQGVVYSANQ | 251 | Q8N6U8 | |
| QIICNTGYRLQNNEN | 111 | Q03591 | |
| TGYRLQNNENNISCV | 116 | Q03591 | |
| QAAQVGDSYSRLQQR | 701 | Q14147 | |
| GTVRLYNRQNCCAQF | 871 | Q6ZTR5 | |
| CQVQNGSETVVQRVY | 66 | Q96A83 | |
| SRAYVAANQRLQQAG | 66 | Q9UFG5 | |
| VQRNLGEALRCYQQS | 401 | Q14154 | |
| VAREKGSQIQYQQVC | 241 | Q3KNS1 | |
| GSQIQYQQVCARYRA | 246 | Q3KNS1 | |
| RYTCVAQNVQGADTR | 496 | Q6UXK5 | |
| VQGALQCYTRAIQIN | 411 | O15294 | |
| QNYGVRATGQQCTEA | 366 | Q96EX2 | |
| AINNFCARVGVTVAQ | 531 | P47897 | |
| QEVCYLRAQQAQRAS | 691 | Q8N1G1 | |
| IRGCQVNQDYFASVN | 341 | O60763 | |
| CVAYNNQSNRLAVSR | 21 | Q969X6 | |
| ITDSCAVYRVNNNRG | 96 | Q9Y5M8 | |
| QYIQQNIRADCSNID | 41 | Q9Y3A3 | |
| ACNNCQRRIVGVRYQ | 216 | Q14596 | |
| NAVNEGTYTCVVRRQ | 361 | O75900 | |
| SRQNAFQVIAVDGVC | 226 | Q9NSN8 | |
| NRGVQQVFECAVRTA | 156 | Q15669 | |
| GIQECFNRSREYQLN | 136 | P09471 | |
| QQATNTCDGRQYGAV | 576 | Q96SF7 | |
| DNENQCDYRTQNVLG | 676 | Q562F6 | |
| DVCYRQASQLEFRQN | 361 | Q86VW0 | |
| RRVANVFTQTCGLQQ | 96 | Q08AH1 | |
| NREQRPGQNCSNYTV | 121 | O75339 | |
| AERSQSANQVCGYVK | 201 | Q6UXN8 | |
| NYNCTAVNRIGQESL | 486 | P13591 | |
| QGIISTFRQCARFQQ | 2816 | Q63HN8 | |
| QRQCSVCRQANEEYQ | 96 | Q13454 | |
| RADDGLYQCTVANNV | 231 | P0DPA2 | |
| QHQRIYIGESSQRCN | 226 | Q8TB69 | |
| VNQAQVQRYVACRTE | 261 | Q92911 | |
| ATVNNRCFQQLDEGY | 241 | Q8TB22 | |
| SFQECQNHLRRYGNV | 136 | Q8IZM8 | |
| ACQDRNVRVYNTVNG | 646 | O43379 | |
| QSYRQEVDRTCANCQ | 411 | O14863 | |
| QYYVQGRNQERLAEC | 821 | Q9P2L0 | |
| QQARYQTACEQPGQK | 446 | Q8IWU6 | |
| RNEAGLQCDQNGQYR | 1516 | P01266 | |
| QIAGNGQTYIRVANC | 606 | Q9Y4A5 | |
| RYTCRAENRLGSQQQ | 331 | Q96RL6 | |
| CGNVFRNTQSLIQYQ | 246 | Q96RE9 | |
| QCQQYVVFERSAKQA | 1136 | O75962 | |
| QNRGNTSECIQYAKD | 236 | Q96MR9 |